FUJIFILM Biotechnologies, a prominent contract development and manufacturing organization (CDMO), is currently experiencing an unprecedented period of expansion, marked by…
Read More
Canada approves generic semaglutide from Dr. Reddy’s, a G7 first enabled by Novo Nordisk’s lapsed CAD$250 patent
In a landmark decision poised to reshape access to one of the world’s most in-demand medications, Health Canada has granted…
Read More
Top pharma companies set sustainability goals, but emissions are still increasing
The global healthcare industry, a cornerstone of human well-being and longevity, is simultaneously a significant contributor to the planet’s environmental…
Read More
Immunai’s digital ‘plumbing’ keeps AstraZeneca coming back
Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has announced a significant expansion…
Read More
Traumatic brain injury and Alzheimer’s disease: Common neuroinflammatory pathologies and therapeutic potential
Traumatic brain injury (TBI) stands as a formidable global health challenge, impacting an estimated 69 million individuals annually across all…
Read More
Beyond PD-1: The drugs reshaping cancer treatment at ASCO 2026
The global biotechnology sector is experiencing a significant resurgence, marked by robust investment, strategic mergers and acquisitions, and groundbreaking scientific…
Read More
Eli Lilly’s Retatrutide Demonstrates Superior Weight Loss Efficacy Amidst Elevated Side Effect Profile in Phase 3 Trials
INDIANAPOLIS, IN – Eli Lilly and Company has announced groundbreaking Phase 3 trial results for its investigational drug, retatrutide, a…
Read More
What if psilocybin works about as well for depression as an SSRI?
The fervent hope surrounding classic psychedelics as a revolutionary treatment for depression may be tempering, with recent data suggesting that…
Read More
Salesforce Lands 140 Life Sciences Clients, Pitches ‘Headless’ AI to Pharma
Boston, MA – As Peter Gassner, CEO of Veeva Systems, a dominant cloud software provider in the life sciences sector,…
Read More
Rubedo turns a senescence-targeting drug on precancerous skin, and sees an efficacy signal without the intense redness
For millions worldwide, the diagnosis of actinic keratoses (AK) initiates a challenging journey to prevent the progression to skin cancer.…
Read MoreYOU MAY HAVE MISSED
